Literature DB >> 35292532

Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient.

Bethany C Birkelo1, Neesh Pannu2, Edward D Siew3,4,5.   

Abstract

Since the description ischuria renalis by William Heberden (1), AKI has remained a prominent complication of critical illness. Beyond KRT, treatment has been limited by the capacity to phenotype this condition. Here, we chronicle the evolution of attempts to classify AKI, including the adoption of consensus definitions, the expansion of diagnosis and prognosis with novel biomarkers, and emerging tools such as artificial intelligence (AI).
Copyright © 2022 by the American Society of Nephrology.

Entities:  

Keywords:  Critical Care Nephrology and Acute Kidney Injury Series; acute kidney injury; epidemiology

Mesh：

Substances：

Year:  2022        PMID： 35292532      PMCID： PMC9269585          DOI： 10.2215/CJN.14181021

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   10.614


  123 in total

1.  Classifying AKI by Urine Output versus Serum Creatinine Level.

Authors:  John A Kellum; Florentina E Sileanu; Raghavan Murugan; Nicole Lucko; Andrew D Shaw; Gilles Clermont
Journal:  J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 10.121

2.  The Development of a Machine Learning Inpatient Acute Kidney Injury Prediction Model.

Authors:  Jay L Koyner; Kyle A Carey; Dana P Edelson; Matthew M Churpek
Journal:  Crit Care Med       Date:  2018-07       Impact factor: 7.598

3.  Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit.

Authors:  Chirag R Parikh; Edward Abraham; Marek Ancukiewicz; Charles L Edelstein
Journal:  J Am Soc Nephrol       Date:  2005-09-07       Impact factor: 10.121

4.  Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function.

Authors:  Zoltán H Endre; John W Pickering; Robert J Walker; Prasad Devarajan; Charles L Edelstein; Joseph V Bonventre; Christopher M Frampton; Michael R Bennett; Qing Ma; Venkata S Sabbisetti; Vishal S Vaidya; Angela M Walcher; Geoffrey M Shaw; Seton J Henderson; Maryam Nejat; John B W Schollum; Peter M George
Journal:  Kidney Int       Date:  2011-02-09       Impact factor: 10.612

5.  Acute renal failure in critically ill patients: a multinational, multicenter study.

Authors:  Shigehiko Uchino; John A Kellum; Rinaldo Bellomo; Gordon S Doig; Hiroshi Morimatsu; Stanislao Morgera; Miet Schetz; Ian Tan; Catherine Bouman; Ettiene Macedo; Noel Gibney; Ashita Tolwani; Claudio Ronco
Journal:  JAMA       Date:  2005-08-17       Impact factor: 56.272

Review 6.  Epidemiology of acute kidney injury: how big is the problem?

Authors:  Eric A J Hoste; Marie Schurgers
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

7.  Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

Authors:  Norbert H Lameire; Adeera Levin; John A Kellum; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Paul E Stevens
Journal:  Kidney Int       Date:  2021-07-09       Impact factor: 10.612

8.  A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.

Authors:  Stuart L Goldstein; Theresa Mottes; Kendria Simpson; Cynthia Barclay; Stephen Muething; David B Haslam; Eric S Kirkendall
Journal:  Kidney Int       Date:  2016-05-21       Impact factor: 10.612

9.  Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population.

Authors:  Dinna N Cruz; Massimo de Cal; Francesco Garzotto; Mark A Perazella; Paolo Lentini; Valentina Corradi; Pasquale Piccinni; Claudio Ronco
Journal:  Intensive Care Med       Date:  2009-12-03       Impact factor: 17.440

10.  Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.

Authors:  Kianoush Kashani; Ali Al-Khafaji; Thomas Ardiles; Antonio Artigas; Sean M Bagshaw; Max Bell; Azra Bihorac; Robert Birkhahn; Cynthia M Cely; Lakhmir S Chawla; Danielle L Davison; Thorsten Feldkamp; Lui G Forni; Michelle Ng Gong; Kyle J Gunnerson; Michael Haase; James Hackett; Patrick M Honore; Eric A J Hoste; Olivier Joannes-Boyau; Michael Joannidis; Patrick Kim; Jay L Koyner; Daniel T Laskowitz; Matthew E Lissauer; Gernot Marx; Peter A McCullough; Scott Mullaney; Marlies Ostermann; Thomas Rimmelé; Nathan I Shapiro; Andrew D Shaw; Jing Shi; Amy M Sprague; Jean-Louis Vincent; Christophe Vinsonneau; Ludwig Wagner; Michael G Walker; R Gentry Wilkerson; Kai Zacharowski; John A Kellum
Journal:  Crit Care       Date:  2013-02-06       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.